Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Indian J Hum Genet ; 2014 Apr-Jun ; 20 (2): 153-154
Artículo en Inglés | IMSEAR | ID: sea-156652

RESUMEN

BACKGROUND: Down’s syndrome is an important congenital chromosomal disorder that can be seen around the world. The antenatal screening for this disorder is an important processing in present obstetrics. OBJECTIVE: Due to the concept of first do no harm, the use of noninvasive test is recommended. The triple marker screening test has been introduced for a few years and acceptable for its effi cacy. RESULT: However, an important concern is on its costeffectiveness. Here, the author analyze and present the cost-effectiveness of the triple markers serum screening for Down’s syndrome in Thai setting. CONCLUSION: According to this work, the cost per effectiveness of triple markers serum screening is slightly lower than standard amniocentesis test.


Asunto(s)
Análisis Costo-Beneficio/métodos , Síndrome de Down/diagnóstico , Síndrome de Down/epidemiología , Marcadores Genéticos/análisis , Marcadores Genéticos/sangre , Humanos , Suero/diagnóstico , Tailandia/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA